Monoclonal antibody active against H5N1 discovered
Crucell N.V. has announced that a
monoclonal antibody that is active against H5N1 avian influenza has been
discoveres by its researchers.
The information regarding this
study will be presented at the 5th International Bird Flu Summit from 27-28
September in Las Vegas, Nevada.
Crucell researchers produced
antibodies in PERC6 cells and tested their biophysical and immunological
"Using phage display technology a
set of human monoclonal antibodies active against a broad range of distinct H5N1
strains was developed," said Crucell chief scientific officer Dr Jaap Goudsmit.
"We will show the ability of these antibodies to prevent infection as well as to
prevent and cure disease caused by H5N1 virus in mice."
Bird Flu Summit
For the latest
poulty news, subscribe here
To comment, login here
Or register to be able to comment.